This federal contract award, valued at $2,735.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, is for the supply of the medication Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a firm fixed price and an ultimate completion date of December 16, 2024. This award is part of Amerisourcebergen's broader role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 IDC with DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering a range of pharmaceutical and medical supply products. The contract award does not have a set-aside designation, indicating open competition.
Generated 3/14/25, 10:03 AM